UTMD Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

Valuation Metrics

The current forward P/E ratio for Utah Medical Products Inc (UTMD.O) is 0.00, compared to its 5-year average forward P/E of 0.00. For a more detailed relative valuation and DCF analysis to assess Utah Medical Products Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

0.00

Current PE

0.00

Overvalued PE

0.00

Undervalued PE

0.00

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

0.00

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

0.00

Undervalued EV/EBITDA

0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A

5Y Average PS

0.00

Current PS

0.00

Overvalued PS

0.00

Undervalued PS

0.00

Financials

Annual

Quarterly

N/A

Total Revenue

N/A

Operating Profit

N/A

Net Income after Tax

N/A

EPS - Diluted

N/A

Free Cash Flow

N/A

Gross Profit Margin - %

N/A

Net Margin - %

N/A

ROIC

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

UTMD News & Events

Events Timeline

No data

News

9.5

10-29NASDAQ.COM

UTMD Reports Year-over-Year Decline in Q3 Earnings Due to Trade Disruptions and Margin Pressures

9.5

07-30NASDAQ.COM

UTMD's Q2 Earnings Slip Y/Y Due to Falling OEM Sales, Stock Down 3%

8.0

07-29NASDAQ.COM

Daily Dividend Report: WELL,PFG,CTVA,UTMD,ENB,WFC

People Also Watch

Frequently Asked Questions

What is Utah Medical Products Inc (UTMD) stock price today?

The current price of UTMD is 57.83 USD — it has decreased -0.46 % in the last trading day.

What is Utah Medical Products Inc (UTMD)'s business?

Utah Medical Products, Inc. develops, manufactures and markets a broad range of disposable and reusable specialty medical devices. The Company has a particular interest in healthcare for women and their babies. The Company’s broad range of products includes those used in critical care areas and the labor and delivery departments of hospitals, as well as outpatient clinics and physicians’ offices. Its products include BT-CATH, CVX-RIPE, AROM-COT, MUC-X, CORDGUARD, DISPOSA-HOOD, DELTRAN PLUS, GESCO, PICC-NATE, LETZ System, Filshie Clip System, PATHFINDER PLUS, SUPRAPUBIC CATHETERIZATION, LIBERTY System, ENDOCURETTE, LUMIN, and BioPharm HP-PRT, among others. BT-CATH is a patented uterine balloon tamponade catheter for controlling severe postpartum hemorrhage. MUC-X is an aspiration device. The Company produces medical devices for blood pressure monitoring and blood management, electrosurgery, labor and delivery, neonatal intensive care, urological care and women’s pelvic health.

What is the price predicton of UTMD Stock?

Wall Street analysts forecast UTMD stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for UTMD is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Utah Medical Products Inc (UTMD)'s revenue for the last quarter?

Utah Medical Products Inc revenue for the last quarter amounts to 9.81M USD, decreased -1.93 % YoY.

What is Utah Medical Products Inc (UTMD)'s earnings per share (EPS) for the last quarter?

Utah Medical Products Inc. EPS for the last quarter amounts to 0.82 USD, decreased -19.61 % YoY.

What changes have occurred in the market's expectations for Utah Medical Products Inc (UTMD)'s fundamentals?

The market is revising No Change the revenue expectations for UTMD for , with the revenue forecasts being adjusted by % over the past three months. During the same period, the stock price has changed by -7.46%.

How many employees does Utah Medical Products Inc (UTMD). have?

Utah Medical Products Inc (UTMD) has 155 emplpoyees as of December 15 2025.

What is Utah Medical Products Inc (UTMD) market cap?

Today UTMD has the market capitalization of 186.13M USD.